[HTML][HTML] Polymeric nanoparticles for drug delivery: Recent developments and future prospects

B Begines, T Ortiz, M Pérez-Aranda, G Martínez… - Nanomaterials, 2020 - mdpi.com
The complexity of some diseases—as well as the inherent toxicity of certain drugs—has led
to an increasing interest in the development and optimization of drug-delivery systems …

[HTML][HTML] Current trends and challenges in cancer management and therapy using designer nanomaterials

PN Navya, A Kaphle, SP Srinivas, SK Bhargava… - Nano convergence, 2019 - Springer
Nanotechnology has the potential to circumvent several drawbacks of conventional
therapeutic formulations. In fact, significant strides have been made towards the application …

[HTML][HTML] Bacteria loaded with glucose polymer and photosensitive ICG silicon-nanoparticles for glioblastoma photothermal immunotherapy

R Sun, M Liu, J Lu, B Chu, Y Yang, B Song… - Nature …, 2022 - nature.com
Bacteria can bypass the blood-brain barrier (BBB), suggesting the possibility of employment
of bacteria for combating central nervous system diseases. Herein, we develop a bacteria …

Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors

FU Din, W Aman, I Ullah, OS Qureshi… - International journal …, 2017 - Taylor & Francis
Nanotechnology has recently gained increased attention for its capability to effectively
diagnose and treat various tumors. Nanocarriers have been used to circumvent the …

[HTML][HTML] Biocompatible polymer nanoparticles for drug delivery applications in cancer and neurodegenerative disorder therapies

E Calzoni, A Cesaretti, A Polchi, A Di Michele… - Journal of functional …, 2019 - mdpi.com
Polymer nanoparticles (NPs) represent one of the most innovative non-invasive approaches
for drug delivery applications. NPs main objective is to convey the therapeutic molecule be …

[HTML][HTML] Aptamers chemistry: Chemical modifications and conjugation strategies

F Odeh, H Nsairat, W Alshaer, MA Ismail, E Esawi… - Molecules, 2019 - mdpi.com
Soon after they were first described in 1990, aptamers were largely recognized as a new
class of biological ligands that can rival antibodies in various analytical, diagnostic, and …

[HTML][HTML] Polymeric nanocarriers of drug delivery systems in cancer therapy

N Avramović, B Mandić, A Savić-Radojević, T Simić - Pharmaceutics, 2020 - mdpi.com
Conventional chemotherapy is the most common therapeutic method for treating cancer by
the application of small toxic molecules thatinteract with DNA and causecell death …

[HTML][HTML] Carrier-free nanodrugs with efficient drug delivery and release for cancer therapy: from intrinsic physicochemical properties to external modification

H Mei, S Cai, D Huang, H Gao, J Cao, B He - Bioactive materials, 2022 - Elsevier
The considerable development of carrier-free nanodrugs has been achieved due to their
high drug-loading capability, simple preparation method, and offering “all-in-one” functional …

Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy

E Pérez-Herrero, A Fernández-Medarde - European journal of …, 2015 - Elsevier
Cancer is the second worldwide cause of death, exceeded only by cardiovascular diseases.
It is characterized by uncontrolled cell proliferation and an absence of cell death that, except …

Polymeric nanoparticles for targeted drug delivery system for cancer therapy

F Masood - Materials Science and Engineering: C, 2016 - Elsevier
A targeted delivery system based on the polymeric nanoparticles as a drug carrier
represents a marvelous avenue for cancer therapy. The pivotal characteristics of this system …